TidemaxxingTidemaxxing
5-Amino-1MQ
Fat Loss

Buy 5-Amino-1MQ — 5 mg Lyophilized Vial

≥98% HPLC purity · lot-matched CoA · sealed under nitrogen

Metabolic-rate investigations — structured for incretin receptor pharmacology.

5-Amino-1MQ is a small-molecule inhibitor of NNMT (nicotinamide N-methyltransferase), an enzyme central to NAD+ salvage and methyl-donor balance. It is actively studied in obesity, metabolic, and sarcopenia research.

from $17.99$19.99SAVE 10%
USD · ships lyophilized · discount auto-applied
Buy 5 mg →
fat-lossmetabolicglp-1
Bac-water math

Reconstitution volumes

Volumes of bacteriostatic water required to dissolve each vial at common research concentrations.

Vialat 2 mg/mLat 5 mg/mLat 10 mg/mL
5 mg2.50 mL1 mL0.50 mL
50 mg25 mL10 mL5 mL

Numbers are calculated from the stated vial mass. Verify against the supplier's instructions for your specific research protocol.

In stock

Available sizes

At a glance

Key facts

  • NNMT inhibitor — small molecule, not a peptide
  • Raises NAD+ precursor availability via NNMT blockade
  • Studied in adipocyte, muscle, and metabolic research
  • Available in oral capsule and injectable research formats
Primer

Mechanism in the literature

NNMT consumes both nicotinamide (an NAD+ precursor) and SAM (the universal methyl donor). Inhibiting NNMT raises nicotinamide availability for NAD+ synthesis and preserves SAM pools — a mechanism proposed to support both metabolic and muscle-biology endpoints.

From the same shelf

Often paired with

Buyers viewing 5-Amino-1MQ typically also consider Tesofensine Capsules, Cagrilintide and AOD9604. Each is in stock, sealed under nitrogen with a lot-matched CoA.

What it's used for

Research use-cases

  • NNMT inhibitor — small molecule, not a peptide
  • Raises NAD+ precursor availability via NNMT blockade
  • Studied in adipocyte, muscle, and metabolic research
  • Available in oral capsule and injectable research formats
Protocol notes

Handling in the lab

Both oral and injectable research routes appear in the literature. Oral capsule formats are convenient for multi-week protocols.

Pairing notes

Stacking and paired-compound work

Comparative protocols sometimes combine 5-Amino-1MQ with direct NAD+ supplementation to study combined NNMT-blockade and NAD+-repletion effects.

Storage and shelf-life

Lyophilized powder is stable at ambient shipping temperatures. Once reconstituted with bacteriostatic water, store at 2–8 °C and use within 28 days. For long-term storage of unreconstituted vials, freeze at −20 °C and protect from light.

Questions we get

Frequently asked

Is 5-Amino-1MQ a peptide?

No — it is a small-molecule NNMT inhibitor (a quinoline derivative), not a peptide. It appears in peptide-research catalogs because it targets NAD+-adjacent biology.

What is NNMT?

Nicotinamide N-methyltransferase — an enzyme that consumes nicotinamide and SAM to produce N-methylnicotinamide. Elevated NNMT activity is linked to obesity in research models.

Oral or injectable?

Both formats are used. Oral capsules suit longer research windows; injectable is used when fast PK is desired.

How does it interact with NAD+ supplementation?

NNMT blockade increases the nicotinamide pool available for NAD+ synthesis — a complementary mechanism to direct NAD+/NMN supplementation.

More Fat Loss compounds

Related reading